Report updated Apr 1, 2026
Mouse Maze - Top Brain Puzzle
v5.1.1Casual gamers and puzzle enthusiasts who enjoy cute, accessible, and addictive mobile games.
What Is Mouse Maze - Top Brain Puzzle?
Launched Sep 22, 2011
Updated Jun 2019
What does it look like?
What are the key features?
Intuitive controls where the mouse follows the user's finger on the screen
Consumable items that allow the player to knock out enemy cats
Ability to unlock and collect various cute character skins
Integration to compare puzzle scores and progress with friends
A wide variety of maze layouts and brain-teasing challenges
What do users think? iIndependent intel reports to help builders create better apps or enhance existing ones. Still in beta, accuracy and relevancy get better every day. For informational purposes only.
Gathering public signals...
Sentiment analysis will be available once enough user reviews are collected.
What are the pros and cons?
Pros
- High user satisfaction with a 4.46-star rating
- Simple, intuitive touch-based control scheme
- Strong 'cute' aesthetic branding
Cons
- Lack of updates since 2019
- Absence of social media presence
- Derivative gameplay mechanics
What is the market outlook?
Growth Opportunities
- Introduce seasonal events and new content
- Implement modern social features like guilds
- Expand character collection with rarity tiers
Market Threats
- High market saturation in the casual puzzle category
- Technical obsolescence due to lack of updates
- Shift in user preference toward narrative-driven puzzles
What are the key takeaways?
Mouse Maze - Top Brain Puzzle is a divisive games app that is free with in-app purchases. With a 4.5/5 rating from 4K reviews, it receives mixed feedback from users.
Best for: Casual gamers and puzzle enthusiasts who enjoy cute, accessible, and addictive mobile games.
How much does it cost?
Model: freemium
The app utilizes a 'free-to-play' model, leveraging high download volume and social virality to drive engagement, with monetization likely supported by ads or consumable IAPs.